ITabMed Ltd.

Private

ShanghaiHealthcare & Life Scienceshttp://itabmed.com/

Last Round

Series A

Dec 1, 2021

Total Funding Raised

$20M

Company Overview

ITabMed Ltd. is a biotechnology company that focuses on the discovery and development of immunotherapy products to treat cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immunotherapyT cell engagerTCEbi-specific antibodytri-specific antibodycancer drug developmentoncologybiotechantibody engineeringbiologicsclinical-stage biotechautoimmune diseasedrug discoveryprecision medicinenext-gen immunotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ITabMed Ltd. Comparables

Compare ITabMed Ltd. with similar companies based on industry and business-model similarity.

ITabMed Ltd. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Excalipoint Therapeutics	84%
Nanjing Leads Biolabs Co Ltd	79%
Merck & Co., Inc.	76%

View all Comparables

ITabMed Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 1, 2021

View all Funding Rounds

ITabMed Ltd. Investors

Notable investors and investment history

ITabMed Ltd. investors
Investor	Rounds
Binhai Venture Capital	Series A
Bencao Capital	Series A
Yonjin Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 1, 2021
$20M round led by Yonjin Capital and Bencao Capital.

View all signals

ITabMed Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ITabMed Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ITabMed Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Employee Range2

Year Founded2020

Last FundingDec 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.